Wellinks is investigating whether its chronic obstructive pulmonary disease (COPD) virtual management program — which offers health coaching, lung…
Articles by Vanda Pinto, PhD
Infection with rhinovirus, a virus that causes the common cold, combined with long-term exposure to cigarette smoke — two risk…
Kaleido Biosciences is teaming up with the COPD Foundation to investigate KB109, a small compound designed to modulate…
One hundred patients have been randomly assigned in Nuvaira’s pivotal AIRFLOW-3 clinical trial that will investigate the efficacy and…
The Emphysema Foundation of America (EFA) — a nonprofit focused on raising awareness of chronic obstructive pulmonary disease (COPD)…
TrialSpark, a technology company that helps streamline the clinical trial process, has partnered with global biopharmaceutical company Sanofi to…
NuvoAir has released a new mobile app for home use, called NuvoAir Cough, that can record and analyze coughing sounds…
Verona Pharma has announced positive efficacy and safety results about using nebulized ensifentrine as an add-on therapy to tiotropium…
Certain risk factors may accurately predict in-hospital mortality, or death, in people with acute exacerbations of chronic obstructive…
Respinova’s new airway device, called Pulsehaler, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).